NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
Launched by UNIVERSITY OF SOUTH FLORIDA · Nov 30, 2020
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The NOURISH-T+ clinical trial is focused on helping pediatric cancer survivors who are at risk of gaining too much weight and not getting enough exercise. Since over 80% of kids with cancer survive into adulthood, it’s important to support their long-term health. This study aims to teach parents and caregivers skills to help prevent and reduce obesity in their children who have survived cancer. Parents can join one of two online groups to learn helpful tips for improving the health of both themselves and their child.
To be eligible for the study, children must be between 5 and 14 years old, have completed their cancer treatment for at least six months, and be living with the participating parent. They should also be at a higher weight category, meaning their body mass index (BMI) is above the 85th percentile. Parents must be the main cook in the household and speak either English or Spanish. Throughout the study, families will receive valuable information and support to encourage healthier eating and physical activity. This program is a great opportunity for families to work together towards a healthier lifestyle after cancer treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Eligible Pediatric Cancer Survivors must be:
- • 1. 5-14 years of age at enrollment;
- • 2. Off active treatment for at least 6 months;
- • 3. At or above the 85th BMI %ile;
- • 4. Able to complete assessments with the help of clinic staff and the USF research team;
- • 5. Residing with the participating parent;
- • 6. Able to engage in PA tailored to current medical status;
- • 7. NOT taking medications that affect body weight (e.g., steroids) within 6 months of enrollment, and
- • 8. In remission -- PCS who experience a relapse of cancer during the intervention will be excused from further involvement.
- • 9. Must be English- or Spanish-speaking
- Participating Parents must:
- • Be either biological or adoptive and/or step mothers or fathers and must be permanent legal guardians of the PCS
- • Be at least 18 years old
- • Identifies as the main meal preparer at home
- • Must be English- or Spanish-speaking
- Exclusion Criteria:
- • Parents are ineligible if they are non-ambulatory and/or do not reside at least 50% of the time with their participating child.
- • Female parents who are currently pregnant will be excluded from the study.
- • Children are ineligible to participate if they are non-ambulatory. In addition, children who are wards of the state will be excluded from the study.
About University Of South Florida
The University of South Florida (USF) is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong commitment to improving patient outcomes, USF leverages its diverse faculty expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. The university fosters collaboration across disciplines, engaging in partnerships that enhance the translation of scientific discoveries into effective therapeutic interventions. USF's clinical trial programs are designed to address pressing health challenges and contribute to the body of knowledge in various medical fields, ultimately aiming to benefit communities and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Atlanta, Georgia, United States
Miami, Florida, United States
Richmond, Virginia, United States
Atlanta, Georgia, United States
Baltimore, Maryland, United States
Miami, Florida, United States
Washington, District Of Columbia, United States
Hackensack, New Jersey, United States
Tampa, Florida, United States
Gainesville, Florida, United States
Patients applied
Trial Officials
Marilyn Stern, PhD
Principal Investigator
University of South Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials